Effects of ludartin and grosshemin on experimental hyperlipidemia induced by triton WR 1339
Abstract
The hypolipidemic action of sesquiterpene γ-lactones ludartin and grosshemin was studied in vivo experiments on the model of acute hyperlipidemia induced by Triton WR 1339. Hyperlipemia model induced by Triton WR 1339, characterized by a sharp increase in the content in the serum of triacylglycerides and total cholesterol, mainly due to the increase of cholesterol in proatherogenic fractions of lipoproteins (low density). Hypolipidemic action of ludartin and grosshemin on the background of triton WR 1339 induced hyperlipemia, and drug comparison of phenofibrate, evident decrease in the content of triacylglycerides and pro-atherogenic cholesterol in low density lipoproteins in the blood serum, as well as reducing the amount of triacylglycerides and cholesterol in the liver of rats.
About the Authors
A. V. Ratkin
Siberian State Medical University
Russian Federation
Russian Federation
634050
Moskovsky trakt, 2
Tomsk
O. A. Kaidash
Siberian State Medical University
Russian Federation
Russian Federation
634050
Moskovsky trakt, 2
Tomsk
V. V. Ivanov
Siberian State Medical University
Russian Federation
Russian Federation
634050
Moskovsky trakt, 2
Tomsk
V. S. Chuchalin
Siberian State Medical University
Russian Federation
Russian Federation
634050
Moskovsky trakt, 2
Tomsk
S. M. Adekenov
JSC «International scientific–industrial holding “Phytochemistry”»
Kazakhstan
Kazakhstan
M. Gazaliyev str., 4
Karaganda
A. I. Vengerovskiy
Siberian State Medical University
Russian Federation
Russian Federation
634050
Moskovsky trakt, 2
Tomsk
References
1. Николаев И. В. Анализ взаимодействия аллелей генов липидного обмена при дислипидемии / И. В. Николаев [и др.] // Вавиловский журн. генетики и селекции. – 2014. – Т. 18, № 4/2. – С. 856–866.
2. Буеверова Е. Л. Атерогенная дислипидемия и печень / Е. Л. Буеверова, О. М. Драпкина, В. Т. Ивашкин // Рос. мед. вести. – 2008. – Т. 13, № 1. – С. 17–23.
3. Ahn C. H., Choi S. H. New drugs for treating dyslipidemia: beyond statins // Diabetes Metab. J. 2015. Vol. 39, N 2. P. 87–94.
4. Короленко Т. А. Изменения фракционного состава липопротеинов сыворотки крови мышей и крыс при липемии, вызванной Тритоном WR 1339 / Т. А. Короленко [и др.] // Бюл. эксперим. биологии и медицины. – 2010. – Т. 149, № 5. – С. 499–502.
5. Логинова В. М. Влияние аторвастатина на липиды сыворотки крови мышей при экспериментальной липемии / В. М. Логинова [и др.] // Бюл. СО РАМН. – 2011. – Т. 31, № 2. – С. 133–137.
6. Адекенов C. М. Сесквитерпеновые лактоны из эндемичных видов семейства Asteraceae / С. М. Адекенов // Химия природ. соединений. – 2013. – № 1. – С. 140–143.
7. Ilan E., Tirosh O., Madar Z. Triacylglycerol-mediated oxidative stress inhibits nitric oxide production in rat isolated hepatocytes // J. Nutr. 2005. Vol. 135, N 9. P. 2090–2095.
8. Millar J. S., Cromley D. A., McCoy M. G. et al. Determining hepatic triglyceride production in mice: comparison of poloxamer 407 with Triton WR-1339 // J. Lipid Res. 2005. Vol. 46. N 9, P. 2023–2028.
9. Tenenbaum A., Fisman E. Z. Fibrates are an essential part of modern anti-dyslipidemic arsenal: spotlight on atherogenic dyslipidemia and residual risk reduction // Cardiovasc. Diabetol. 2012. Vol. 11, N 125, P. 1–10.
Review
For citations:
Ratkin A.V., Kaidash O.A., Ivanov V.V., Chuchalin V.S., Adekenov S.M., Vengerovskiy A.I. Effects of ludartin and grosshemin on experimental hyperlipidemia induced by triton WR 1339. Ateroscleroz. 2015;11(4):33-36. (In Russ.)
Views:
205
Email this article 